InflaRx IFRX
NASDAQ IFRX
$2.05 -0.04 (-1.91%)
As of: Sep 10, 2026 · 3:59 PM EDT

InflaRx (IFRX) Retained Earnings (2016 - 2026)

InflaRx's (IFRX) quarterly Retained Earnings came in at -$458.0 million in Q2 2026, down 14.01% year-over-year from -$532.7 million in Q2 2025, and down 2.04% quarter-over-quarter from -$448.9 million in Q1 2026.

Analysis

InflaRx (IFRX) Retained Earnings (2016 - 2026) Analysis & Trends

InflaRx has disclosed Retained Earnings across 11 years of filings, most recently posting -$458.0 million for Q2 2026.

  • In Q2 2026, Retained Earnings fell 14.01% year-over-year to -$458.0 million; the TTM figure through Jun 2026 stood at -$458.0 million (down 14.01% YoY), while the FY2025 annual figure was -$426.9 million, down 20.25% from the prior year.
  • Retained Earnings came in at -$458.0 million for Q2 2026 at InflaRx, down from -$448.9 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$237.4 million in Q3 2022 to a low of -$458.0 million in Q2 2026.
  • Average Retained Earnings over 5 years is -$336.1 million, with a median of -$327.4 million recorded in 2024.
  • Year-over-year, Retained Earnings grew 0.01% in 2022 and dropped 25.33% in 2026.
  • Over 5 years, Retained Earnings stood at -$248.4 million in 2022, then fell by 23.94% to -$307.9 million in 2023, then retreated by 15.31% to -$355.0 million in 2024, then declined by 23.9% to -$439.8 million in 2025, then slipped by 4.15% to -$458.0 million in 2026.
  • Per Business Quant data, the three most recent Retained Earnings figures were -$458.0 million in Q2 2026, -$448.9 million in Q1 2026, and -$439.8 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn -22.28 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 9.53 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 15.69 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 37.62 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 558.00 Mn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 5.10 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -6.33 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 20.97 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 5.13 Bn
10 InflaRx 139.29 Mn -44.96 Mn 2.74 Mn -458.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -458.05 Mn
Mar 31, 2026 -448.89 Mn
Dec 31, 2025 -439.81 Mn
Sep 30, 2025 -429.26 Mn
Jun 30, 2025 -401.76 Mn
Mar 31, 2025 -358.17 Mn
Dec 31, 2024 -354.98 Mn
Sep 30, 2024 -359.21 Mn
Jun 30, 2024 -333.44 Mn
Mar 31, 2024 -321.33 Mn
Dec 31, 2023 -307.86 Mn
Sep 30, 2023 -294.13 Mn
Jun 30, 2023 -286.11 Mn
Mar 31, 2023 -273.21 Mn
Dec 31, 2022 -248.39 Mn
Sep 30, 2022 -237.38 Mn
Jun 30, 2022 -242.77 Mn
Mar 31, 2022 -255.87 Mn
Dec 31, 2021 -244.78 Mn
Sep 30, 2021 -237.40 Mn